Levodopa—the gold-standard treatment for Parkinson's disease—increases dopamine in the brain. But as the disease progresses ...

The disease, which affects 1.5 million people in the U.S., is characterized by tremors, rigid posture, loss of balance, and ...

The future of treating brain diseases could lie in non-invasive technologies, according to Chongqing Haifu Medical Technology ...

A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness, coordination, ...

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...

An experimental drug designed to silence a gene strongly linked to Parkinson's disease has shown encouraging effects in a ...

The Michael J. Fox Foundation for Parkinson's Research (MJFF) has started working with Swiss biotech Biognosys on a project ...

Parkinson’s disease affects more than 1.1 million people in the U.S., according to the Parkinson’s Foundation.

How well our brain functions depends heavily on the performance of our nerve cells. That is why they are regularly checked for their proper function -- defective cell components are marked, disposed ...

Scientists have shown that plastic bottles could be converted into levodopa, an important Parkinson’s drug, with implications ...

April is Parkinson’s Awareness Month. Some people may be asking what Parkinson’s disease is, while others already have a very intimate knowledge and are dealing with the disease every day. According ...